Description

Spiro[Cyclopentane-1,2-[2H]Imidazo[4,5-B]Pyridine] (9Ci) is a high-purity, advanced pharmaceutical intermediate characterized by its unique spirocyclic fused-ring structure. This compound is of significant value in medicinal chemistry for its role as a sophisticated building block in the synthesis of novel active pharmaceutical ingredients (APIs). It is primarily sought after by research institutions and pharmaceutical companies engaged in the development of new therapeutic agents, particularly within oncology and central nervous system (CNS) drug discovery pipelines.

Application

• Pharmaceutical Intermediate: A key building block in the multi-step synthesis of complex drug candidates and novel active pharmaceutical ingredients (APIs).
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization for new therapeutic targets.
• Organic Synthesis Reagent: Employed in academic and industrial laboratories for constructing complex heterocyclic frameworks.
• Pre-clinical Drug Development: Serves as a critical material in the synthesis of compounds for pharmacological screening and pre-clinical evaluation.

Basic Information

Product Name	Spiro[Cyclopentane-1,2-[2H]Imidazo[4,5-B]Pyridine] (9Ci)
CAS No.	885481-93-6
Molecular Formula	C9H11N3
Molecular Weight	161.21 g/mol
Synonyms	Spiro[cyclopentane-1,2'-imidazo[4,5-b]pyridine]; 1'H-Spiro[cyclopentane-1,2'-imidazo[4,5-b]pyridine]; Spiro(cyclopentane-1,2'-[2H]imidazo[4,5-b]pyridine); 885481-93-6; Spirocyclopentane-imidazopyridine; Spirocyclic imidazopyridine derivative
EINECS	Contact for details

Quality Control

Our Spiro[Cyclopentane-1,2-[2H]Imidazo[4,5-B]Pyridine] (9Ci) is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC, NMR, and MS, to ensure identity, purity, and consistency. We provide comprehensive Certificates of Analysis (COA) with every shipment, detailing all specifications and test results. Our quality commitment aligns with the standards required for pharmaceutical R&D and cGMP principles where applicable.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). Keep away from incompatible materials. For long-term storage, consider storing under an inert atmosphere to ensure optimal stability.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.